Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-056918
Filing Date
2014-09-19
Accepted
2014-09-19 16:15:27
Documents
1
Period of Report
2010-12-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v389670_3.html 3  
1 OWNERSHIP DOCUMENT v389670_3.xml 3 5072
  Complete submission text file 0001144204-14-056918.txt   6776
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 ALMANOR AVENUE SUNNYVALE CA 94085
Business Address
HARRIS ROBERT LEWIS (Reporting) CIK: 0001567140 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55016 | Film No.: 141112242